FDG-PET/CT tumor to liver SUV ratio (TLR), tumor SUVmax, and tumor size: can this help in differentiating squamous cell carcinoma from adenocarcinoma of the lung?
Abstract Background PET/CT plays an essential role in the diagnosis, staging, and follow-up of lung cancer. We aimed to assess the ability of PET/CT to differentiate between adenocarcinomas (AC) and squamous cell carcinomas (SCC) of the lung using tumor size, tumor maximum standardized uptake value...
Main Authors: | Amr Muhammad Abdo Salem, Laila Hosny Hussein, Ahmed M. Osman |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2022-05-01
|
Series: | The Egyptian Journal of Radiology and Nuclear Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43055-022-00782-4 |
Similar Items
-
Pretreatment SUVmax value to predict outcome in patients with stage III NSCLC receiving concurrent chemoradiotherapy
by: Gokhan Yaprak, et al.
Published: (2019-06-01) -
Prognostic value of pre-treatment FDG PET/CT SUVmax for metastatic lesions in de novo metastatic nasopharyngeal carcinoma following chemotherapy and locoregional radiotherapy
by: Wenbin Yan, et al.
Published: (2023-02-01) -
Prediction of 2-[<sup>18</sup>F]FDG PET-CT SUVmax for Adrenal Mass Characterization: A CT Radiomics Feasibility Study
by: Arnaldo Stanzione, et al.
Published: (2023-06-01) -
Response criteria in solid tumors (PERCIST/RECIST) and SUVmax in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy
by: Cory Pierson, et al.
Published: (2018-02-01) -
Analysis of the Role of PET/CT SUVmax in Prognosis and Its Correlation with
Clinicopathological Characteristics in Resectable Lung Squamous Cell Carcinoma
by: Hongliang REN, et al.
Published: (2016-04-01)